Effect of neoadjuvant chemotherapy on primary treatment interval in patients with advanced ovarian cancer
Int J Gynecol Cancer
.
2011 Dec;21(9):1517.
doi: 10.1097/IGC.0b013e318223e2a4.
Authors
Maria Luisa Gasparri
,
Giorgia Perniola
,
Violante Di Donato
PMID:
22123709
DOI:
10.1097/IGC.0b013e318223e2a4
No abstract available
Publication types
Letter
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Female
Humans
Ovarian Neoplasms / drug therapy*
Ovarian Neoplasms / surgery*